Get access to our best features
Get access to our best features
Published

23andMe board quits over plans to take DNA testing company private

  • The 23andMe board of directors resigned, stating they differed on the company’s strategic direction and believed resignation was best for the company and its shareholders.
  • Anne Wojcicki expressed surprise and disappointment over the resignations and reaffirmed her commitment to taking 23andMe private.
  • Wojcicki stated that going private would enhance long-term success by reducing short-term pressures from public markets and emphasized her commitment to stakeholders.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 58% of the sources are Center
58% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)